General Information
Drug ID
DR01188
Drug Name
Ciprofibrate
Synonyms
2-(4-(2,2-Dichlorocyclopropyl)phenoxy)2-methylpropanoic acid; 2-(p-(2,2-Dichlorocyclopropyl)phenoxy)-2-methylpropionic acid; 2-[4-(2,2-Dichlorocyclopropyl)phenoxy]-2-methylpropanoic acid; 2-[p-(2,2-Dichlorocyclopropyl)phenoxy]-2-methylpropanoic acid; 2-{4-[2,2-dichlorocyclopropyl]phenoxy}-2-methylpropanoic acid; 2-{[4-(2,2-dichlorocyclopropyl)phenyl]oxy}-2-methylpropanoic acid; C 0330; Ciprofibrate (USAN/INN); Ciprofibrate [USAN:BAN:INN]; Ciprofibrato; Ciprofibrato [INN-Spanish]; Ciprofibratum; Ciprofibratum [INN-Latin]; Ciprol; Hiperlipen; Hyperlipen; Lipanor; Modalim; Oroxadin; Sanofi Synthelabo brand of ciprofibrate; Sanofi Winthrop brand of ciprofibrate; WIN 35833; Win 35,833; Win-35833
Drug Type
Small molecular drug
Therapeutic Class
Anticancer Agents
Structure
3D MOL 2D MOL
Formula
C13H14Cl2O3
Canonical SMILES
CC(C)(C(=O)O)OC1=CC=C(C=C1)C2CC2(Cl)Cl
InChI
InChI=1S/C13H14Cl2O3/c1-12(2,11(16)17)18-9-5-3-8(4-6-9)10-7-13(10,14)15/h3-6,10H,7H2,1-2H3,(H,16,17)
InChIKey
KPSRODZRAIWAKH-UHFFFAOYSA-N
CAS Number
CAS 52214-84-3
Pharmaceutical Properties Molecular Weight 289.15 Topological Polar Surface Area 46.5
Heavy Atom Count 18 Rotatable Bond Count 4
Hydrogen Bond Donor Count 1 Hydrogen Bond Acceptor Count 3
XLogP
3.4
PubChem CID
2763
PubChem SID
103689672 , 103914561 , 104301538 , 10852034 , 11467104 , 11468224 , 11486732 , 117868533 , 12013723 , 121360841 , 121363669 , 124749506 , 14775650 , 17397655 , 17404731 , 24278288 , 26757866 , 28325632 , 29221918 , 47291293 , 47291294 , 47365389 , 47736670 , 47959950 , 4816527 , 48413469 , 48415783 , 49699279 , 49857263 , 50105908 , 50105909 , 50889815 , 53777274 , 53789241 , 56311292 , 56312796 , 56312797 , 56352999 , 56463556 , 57321443 , 7978950 , 8151784 , 85175392 , 85230953 , 85788082 , 90340632 , 91011906 , 92125998 , 92303711 , 92713293
ChEBI ID
ChEBI:50867
TTD Drug ID
D0EJ6O

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.